羊胎素及其免疫调节功能的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
羊胎素就是指羊胚胎或胎盘(统称为羊胎)中的活性物质。通过查阅大量的文献资料得知,羊胎中的活性物质主要是小分子多肽类物质。此外,羊胎中也含有丰富的氨基酸,包括人体所必需的8种氨基酸。本文以羊胚胎及胎盘为研究对象,利用超滤法提取其中的主要生物活性成分,对活性成分提取后的剩余蛋白质进行了酶水解,选择了适用于羊胎水解的最适酶种类及最适水解条件。对酶水解液进行了乳酸发酵,筛选出最适发酵菌种及最适发酵条件。并对水提液、水提液+水解液、水提液+发酵液进行了免疫调节功能评价和对比,对水提液(小分子多肽)的加工稳定性进行了研究,并对羊胎素口服液进行了安全性毒理学评价。结果表明:
     采用目前较为成熟的超滤法提取羊胎中的活性物质,所得小分子肽为无色或微黄色透明液体,pH6.8~7.2,采用聚丙酰胺凝胶电泳测定其分子量介于3800~10 000Dal之间。紫外扫描分析,最大紫外吸收波长在256nm附近,紫外吸收光密度E_(260)/E_(280)≥2.0,表明该物质为核苷酸和肽类物质,多肽含量为797.22±107.07ug/ml。
     以水解度和氮收率为指标,通过中性蛋白酶、胃蛋白酶、胰酶和木瓜蛋白酶4种蛋白酶对羊胎蛋白质水解效率的比较,选择胰酶为水解羊胎的最适酶。通过均匀设计法选得羊胎水解的最适条件为酶用量2.5%(100g原料加胰酶2.5g),底物浓度5.0%(100ml水中加原料5.0g),反应温度40℃,反应时间3h,此时水解度为39.28%。羊胎水解液中含有19种组成蛋白质的氨基酸,包括人体所必需的8种氨基酸,其游离氨基酸总量为45.37mg/ml。
     乳酸发酵可脱除羊胎水解液中的苦味和腥味,改善羊胎水解液的感官品质。适用于羊胎水解液发酵的微生物菌种组合为嗜酸乳杆菌1.1854与嗜热链球菌1.1855。通过发酵参数的单因子试验及正交试验得出最优发酵条件为:1.1854与1.1855配比4:1、接种量5%、发酵温度39℃、发酵时间20h、最适糖种类及用量为乳糖2%、发酵起始pH6.5。发酵后水解液中部分与苦味有关的疏水性氨基酸的含量增加,从而使水解液苦味降低。
     动物试验表明,低剂量羊胎水提液可抑制SRBC所致的迟发性变态反应,提高小鼠血清溶血素水平,增强小鼠特异性免疫功能;可极显著增强单核-巨噬细胞吞噬功能,增强小鼠非特异性免疫功能,因此具有免疫调节作用。
    
     羊胎蛋白质水解液+水提液或水解液+A酵液对小鼠的非特异性免疫功能较
    水提液有显著提高(P功.05),也即水解液或发酵液对小鼠的免疫功能具有提
    高作用。水解液经发酵后与水解液的功能相比无显著提高(P>0.05),但测定
    值有一定的提高。
     温度、。pH、胃蛋白酶对小分子肽的免疫活性有一定的影响.随着温度的升
    高,小分子肽的免疫活性降低。在 pH3-10的范围内,小分子肽相对稳定,
    免疫活性变化很小。胃蛋白酶可以将小分子肽水解为游离氨基酸,从而使其活
    性降低。
     大、,1、鼠经口急性毒性试验,羊胎素口服液 LDw均>10.00wg体重,属
    实际无毒.30天喂养试验表明,较长期受试羊胎素口服液对大鼠生长、发育、
    血液、生化、病理等指标未见异常,30天喂养最大无作用剂量>5 00()mgh
    体重。
In this paper, we extracted the bioactive composition of goat embryos with the ultrafiltration and studied its physical and chemical characters; hydrolyzed the protein of the goat embryos with different proteases; selected the optimal hydrolyzed condition, screened the optimal strains and condition of lactic acid ferment; evaluated the function of the extract with water, extract with water and hydrolyzed products of protein, extract with water and fermented products of hydrolyzed products. The results of research are summed up as the followings:
    The extract with water of dark goat embryos is colorless or light yellow; its molecular weight is between 3800 ~ 10 OOODal. The maximum absorb wavelength is around 256nm; E260/E2go > 2.0 shows its nature is polypeptide; the content of polypeptide is about 797.22 ?107.07ug/ml.
    According to the DH% and recieval of nitrogen degree, we selected the pancreatin as the optimal enzyme from the neutral protease, pepsin, papain and pancreatin. The best hydrolyzed condition is 2.5g pancreatin/lOOgmaterial, 5.0g substrate/100ml water, reacting in 40 癈 for three hours. The hydrolyzed products includes nineteen kinds of amino acids; the total amount of free amino acids is 45.37mg/ml
    Fermented with Lactic acid bacteria, the sense of the hydrolyzed products is improved greatly. The optimal ferment condition is 1.1854:1.1855=4:1,inoculated amount 5%, 39癈 for 20 hours with 2% lactose, initial pH 6.5.
    The extract of goat embryos can effectively enhance the cellar immunity and
    
    
    humoral immunity, specific and nonspecific immunity of mouse. But the hydrolyzed products + extract and fermented products + extract have no distinguished difference with each other.
    Temperature, pH and pepsin all can influence the activity of the extract. With the Temperature advancing, the activity of the extract cuts down. Within pH3 ~ 10, the activity of the extract is relatively stable. Pepsin can hydrolyze the peptide to low its activity.
    The LD50 of Juice of goat embryos by the rat and mice is more than 10.00g/kg. The result of experiment of 30 days feeding shows the extract has no bad effect on the growth, development, blood, pathology and the maximum dose without action is more than 5 000mg/kg.
引文
1.Klerk, H. C. and Smith, J. A. Properties of lactobacillus fermenti Bacteriocin. J. Gen. Microbiol. 1987, 133(2): 309-314
    2.Nettle, P. M. and Barefoot, S. F. bateriocin of food associated lactic acid bacteria. J. Food Prot. 1993, 56(1): 56-58
    3.Daechei, M. A. and Mormine, R.. E. Stability of the bacteriocin and its effect on growth of pediococcus pentosaceus. Abstr. Annu. Meet. Am. Soc. Microbiol, 1987,(87):343-351
    4.Bramley T A. Colonystimulating factor in conceptus and uterine tissues in pigs. Placenta. 1992,13:555-581
    5.Shen-Lin. Transforming growth factor beta in bovine placentaa..J Clin Endocrinal Metab. 1995,80:580~588
    6.Perkins AV. Assessment of expression of the receptor for colonystimulating fortor in bovine trophoblast.. Placenta. 1995,16:233~243
    7.Petraglia F. Localization and quantification of insulin-like growth factor-I(IGF-I) and IGF-I receptors in pig embryos during early pregnancy. Mol Cell Endocrinol. 1991, 78:109~112
    8.Chibbar R Dectection of insulin-like factor binding protein in cat. J Clin Endocrinoi Metab. 1995,80:567~574
    9.Hirst J J. Purification and characterization of a bovine pregnacy-associated glycoprotein.. Semin Reprod Endocrinol. 1993,11:219~225
    10.Petraglia F. The gene encoding bovine pregnancy-associated glycoprotin, an inactive memtrophectoderm.. Endocrinology. 1989,124:2016~2023
    11.Muttukrishna. Biological and immuoiogical activities of bovine placental gonadotropin. Clin Endocrinology. 1995,42:391~399
    12.Yokoyama Y, Warren W C, Eppard P J, et al. Ruminant placental lactogens:structre and biology. J Clin Endocrinol Metab. 1995, 80:915~921
    13.Petraglia F, Georgieva R, Stefanov D, et al. Effects of the whole extract and the chromatographic fractions of the pig placenta on lymphocyte proliferation and humorai immune response. J Clin Endocrinol Metab. 1994,78:205~211
    14.Lacroix M C, Furbass R, Vanselow J. et al. An aromatase pseudogene is transcribed in bovine placenta. J Endocrinology. 1995, 144:179~191
    15.Gluckman P D. Porcine prignancy-associated glycoproteins:new members of the aspartic proteinase gene family expressed in trophectrderm.. J Clin Endocrinol Metab. 1995, 50:1047~1055
    16.Szafranska B, Xie S C, Harrison~Woolrych et al. Prification, characterization and cDNA cloning of Kunitz-type proteinase inhibitor secreted by the porcine uterus. J Clin Endocrinol Metab. 1994,78: 1179~1184
    
    
    17.Furbass R, Vaaseiow J, Matsuzaki N,et al. An aromatase pseudogene is transcribed in bovine placenta. J Ciin Endocrinol Metab. 1992,74:211~216
    18.Masuhiro K, Xie S, Low B G, et al. Thophoblast-specific processing and phosphorylation of pregnancy-associated glycoprotein-l in day 15 to 25 sheep placenta. J Clin Endocrinol Metab. 1991, 72: 592
    19.Murray D. Characterization of placentation-specific binucleate cell glycoproteins possessing a novel carbohydrate:evidence for a new family of pregnancy-assosiated molecules. Placenta. 1993,14:249~275
    20.Vanselow J, Furbass R, Murray D, et al. Novel aromatase transcripts from bovine placenta contain repeated sequence motifs. Semin Perinatol. 1991,15:210~224
    21.Pescador N, Stefanov D, Pollard JW et al. Steroidogenic acute regulatory protein in bovine corpora lutes. Nature. 1987, 330: 484~486
    22.Dudley D J, Murphy R A, Oger J, et al. Secretion of nerve growth factor by central nervous system glioma cells in culture. Biol Reprod. 1993,48:33~39
    23.Sawai K, R. Kanagasunteeram, M. Ramsbotham., et al. Development of the human nasopharyngeal epithelium. J Clin Endocrinol Metab. 1995, 50:1449~1452
    24.Goldin B R and L Gorbach. Am. Neoplastic transformation of human embryonic nasopharyngeal epithelial cells induced by DNP in vitro. J.Clin., 1984(39):756~762
    25.Hichey M W, Stanley Fahn. Fetal tissue transplants in parkinson's desease.. J.appl. Bact., 1983,(22):360~366
    26.Puban Z. Transplantation of fetal mesencephalic tissue in parkinson's desease. Bulletin of the IDF, 1988,(71): 267~271
    27.Dellaglio F. Are there really alternatives to the use of fetal tissue from elective abortions in transplantation research? Bulletin of the IDF, 1998(227):75~79
    28.Gottschalk G. The SCID-humouse:murine model for the analysis of human hematolymphoid defferentiation and function. Bacterial metabolishk,p.214.New York, 1985
    29.Michko W. et al..Debittering of a tryptic hydrolysates of casein by incubating with the ice nucleation-active bacterium. Erwinia anans and its aminoprptidases at low temperature Agric.Bioc. Chem. 1990,54(12):3351~3353
    30.K.D.Lee et al..Debittering mechanism of bitter peptides extracted from cheddar cheese with peptidases from Lactoccus lactis ssp. Cremoris Skll.J.Dairy Sci.. 1996,79(9): 1521~1528
    31.K.H.Ney. Lehensm. The effect of human reconbinant tumor necrosis factor on glioma-derived cell liner on. Untersuch,forsch, 1972, (147):64~70
    32.T. godfrey. Experimental study of the placental immunoregulation factor. Industrial Enzymology. 1996: 179~186
    33.J.Adler-Nissen et al. Chemistry of Foods and Bevrages-Recent Developments. New York Academic Press, 1982
    34.J.Adler-Nissen, Mitchell. Functional expression of receptors in microorgnisms. ACS Sysmp. Ser. 1979,(92):125~129
    
    
    35.K.H.Ney, Lebensm. Characterization of human kinase:high mRNA expression in immune cells and muscle tissue. Umersuch,forsch, 1971, (149):321~325
    36.Coventry. J.F. Growth characteristics of meat starter culture, Meat Sci., 1991,30(1):41~53
    37.Acton,J.C.et al..Utilization of various carbohydrates in fermented sausage,J.Food Sci.1977,42(1):174~178
    38.Brsdford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem.,1976,(72):248~255
    39.梁积恒.胎盘免疫调节因子临床应用进展.广西医科大学学报,1997,14(1):148~149
    40.王国贤,边学义,齐志敏,等.胎盘因子对小鼠四氯化碳肝损伤的保护作用.中国生化药物杂志,1997,18(5):238~240
    41.许代娣,李琪.胎盘免疫调节因子的研究现状.广西医科大学学报,1999,16(2):1~3
    42.马布仁,李素华,谢勋,等.胎盘免疫活性的实验研究.解放军医学杂志.1988,13(5):335
    43.丰慧根.胎盘免疫调节肽对免疫抑制小鼠的免疫作用.新乡医学院学报,1995,12(2):134~136
    44.杨琨,舒翠玲,赵宁,等.胎盘因子对机体细胞免疫功能的调节作用.中国中西医结合杂志,1992,12(8):487
    45.李恩善,董邦全,杨琨,等.胎盘免疫调节因子理化性质及生物学活性的实验研究.上海免疫学杂志,1993,13(4):204~205
    46.梁积恒,张丽生,张力图,等.胎盘免疫调节因子治疗恶性肿瘤 313 例的临床观察.广西医学,199,21(1):1~3
    47.曹金旭,于宪基,张放中,等.胎盘肽治疗反复呼吸道感染儿童疗效观察.上海免疫学杂志,1992,12(3):167
    48.黄宁玲,黄红,齐准.胎盘免疫活性肽对上呼吸道感染儿童防治研究.河北医药,1994,16(2):73~74
    49.彭立义,杨道理,齐法蓬,等.胎盘免疫调节肽治疗肿瘤 100 例疗效与免疫功能观察.实用肿瘤杂志,1992,4(1):36~37
    50.周义,吴明,张华,等.胎盘肽治疗乙型肝炎的疗效观察.徐州医学院学报,1991,11(3):234~235
    51.张曙光,孙思才,韩纪举.乙型肝炎在特异性胎盘肽治疗中 T 淋巴细胞亚群的变化.前卫医药杂志,1991,8(2):89~90
    52.谭骏,王燕,纪贤文,等.人胚小分子物质对~(60)Co-γ射线照射小鼠所致骨髓抑制的恢复作用.第三军医大学学报,1992,14(3):289~290
    53.人胚小分子物质对小鼠免疫功能调节作用的研究.免疫学杂志,1993,9(4):239~241
    54.宋燕爽,杨毅,李川,等.人胚胎提取液生物学活性研究及临床应用展望.中国肿瘤临床,1996,23(2):92~96
    55.蒋克珉,柯明文,戴君禄,等.人胎胸腺素对结核患者 T 细胞亚群分布的影响.中国生化药物杂志,1996,17(1):30~32
    56.王凤山,张天民,张子刚,等.不同免疫活性人胚胸腺提取物的研究.中国免疫学杂志,1987,3(3):148~150
    57.钟建庭,徐淑芬,达万明,等.人胚胎素联合 PLS 方案治疗再生障碍性贫血.现代诊断与治疗,1995,6(5):294
    58.任东鲜,朱未,洪今顺,等.应用绵羊肝细胞生长因子治疗小鼠急性中毒性肝损伤的疗效.中
    
    国生物制品学杂志,1997,10(1):55~58
    59.白海,吴祖泽.人胎肝中低分子天然抑瘤物对小鼠肉瘤S-180作用的研究.中国应用生理学杂志,1991,7(2):97
    60.李滨胜.禽胚胎因子提取方法及药物用途.专利,申请号 94110423
    61.汤先析.人胎脑磷脂的提取及在化妆品上的应用.专利,申请号 94114153
    62.李玉波.神经生长因子生产技术.专利
    63.李宝才,闻克威,盛国英,等.羊胎水解液类脂化学组成的研究.食品科学,2000,21(1):9~10
    64.郑建仙.功能性食品.中国轻工业出版社,1995
    65.GB15193.1-19-14 食品安全性毒理学评价程序和方法
    66.GB16740—1997 保健(功能)食品通用标准
    67.熊善柏、王启明、赵山.乌鸡肉蛋白质分步酶解工艺与水解液澄清方法研究.食品工业科技,2000,21(4);56~58
    68.熊明民、徐幸莲、陈伯祥.乌骨鸡肉酶解条件的研究.肉类研究,1997,(3)16~19
    69.黄文涛,胡学智.酶应用手册.上海.科学技术出版社,1989
    70.王璋.食品酶学.北京.轻工出版社,1990
    71.熊燕飞,王惠平,陈怀新,等.酶法水解蚕蛹蛋白制备多肽的工艺研究.湖北大学学报,1999,21(3):18~20.
    72.李季伦等.微生物生理学[M].北京农业出版社,1993
    73.毛建伟等.肉类发酵混合培养菌种的选择.食品科学,1991,12(1):21~25
    74.乔发东.超滤技术制备浓缩乳酸菌发酵剂的研究.中国畜产与食品.1998,5(2):112~113
    75.王遂,尤旭.微生物蛋白酶对玉米皮蛋白水解作用的研究.食品工业科技,2000,21(4):22~24
    76.赵国华,陈宗道,罗爱民.蛋白质水解物苦味研究进展.粮油食品科技,1999,7(3):
    77.杨兰,刘通讯.酶法水解鸡肉蛋白及其水解液脱苦方法的研究.食品工业科,1999,20(2):4~
    78.武建晔.羊肉加工利用现状.肉类工业,1996,(9):21~23
    79.卫生部卫生监督司《保健食品功能学评价程序和检验方法》
    80.李衡,王季,区明勋.食品感官鉴定方法及实践.上海科学技术出版杜,1990
    81.朱纪.食品感官分析入门.中国轻工出版社,1990
    82.中华人民共和国国家标准,乳酸菌饮料中乳酸菌的微生物学检验GB/T 16347---1996
    83.崔月梨.中华人民共和国药典(二部).北京:人民卫生出版杜,1990:465
    84.刘泽隆等.家畜胎盘生物活性物质的研究进展.西北农业大学学报,1999,27(1):82~87
    85.帝新宇.人胎盘生物活性物质研究进展.国外医学生理、病理科学与临床分册.1997,17(1):38~41

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700